Intuitive Surgical Inc (ISRG) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Intuitive Surgical Inc stock (ISRG) is currently trading at $477.97. Intuitive Surgical Inc PE ratio is 60.58. Intuitive Surgical Inc PS ratio (Price-to-Sales) is 16.87. Analyst consensus price target for ISRG is $606.53. WallStSmart rates ISRG as Hold.
Intuitive Surgical Inc (ISRG) stock price prediction for 2030: Base case $205.94. Bull case $257.43. Bear case $154.46. See full ISRG 2030 price forecast and methodology on WallStSmart.
- ISRG PE ratio analysis and historical PE chart
- ISRG PS ratio (Price-to-Sales) history and trend
- ISRG intrinsic value — DCF, Graham Number, EPV models
- ISRG stock price prediction 2025 2026 2027 2028 2029 2030
- ISRG fair value vs current price
- ISRG insider transactions and insider buying
- Is ISRG undervalued or overvalued?
- Intuitive Surgical Inc financial analysis — revenue, earnings, cash flow
- ISRG Piotroski F-Score and Altman Z-Score
- ISRG analyst price target and Smart Rating
Intuitive Surgical Inc
📊 No data available
Try selecting a different time range
ISRG Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Intuitive Surgical Inc (ISRG)
ISRG trades 82% above its Graham fair value of $263.21, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Intuitive Surgical Inc (ISRG) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, operating margin, profit margin. Concerns around price/sales and price/book. Fundamentals are solid but monitor weak areas for improvement.
Intuitive Surgical Inc (ISRG) Key Strengths (5)
Keeps $30 of every $100 in revenue after operating costs
Keeps $28 of every $100 in revenue as net profit
89.14% of shares held by major funds and institutions
Large-cap company with substantial market presence
Solid profitability: $17 profit per $100 equity
Supporting Valuation Data
Intuitive Surgical Inc (ISRG) Areas to Watch (5)
Very expensive at 16.9x annual revenue
Very expensive at 9.5x book value
Paying a premium for growth, expensive relative to earnings expansion
Solid revenue growth at 18.80% per year
Solid earnings growth at 16.60%
Supporting Valuation Data
Intuitive Surgical Inc (ISRG) Detailed Analysis Report
Overall Assessment
This company scores 62/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 5 register as strengths (avg 9.2/10) while 5 fall into concern territory (avg 4.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Operating Margin, Profit Margin, Institutional Own.. Profitability is solid with Return on Equity at 16.70%, Operating Margin at 30.20%, Profit Margin at 28.40%.
The Bear Case
The primary concerns are Price/Sales, Price/Book, PEG Ratio. Some valuation metrics including PEG Ratio (2.46), Price/Sales (16.87), Price/Book (9.52) suggest expensive pricing. Growth concerns include Revenue Growth at 18.80%, EPS Growth at 16.60%, which may limit upside.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Sales improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 16.70% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 18.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Operating Margin, Profit Margin) and negatives (Price/Sales, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
Compare ISRG with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Intuitive Surgical Inc (ISRG) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Intuitive Surgical Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 10.1B with 19% growth year-over-year. Profit margins are strong at 28.4%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 1670.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 28.4% and operating margin of 30.2% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Valuation compression risk at a P/E of 60.6x. Any growth miss could trigger a sharp correction.
Volatility is elevated with a beta of 1.68, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Intuitive Surgical Inc.
Bottom Line
Intuitive Surgical Inc offers an attractive blend of growth (19% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(202 last 3 months)
| Insider | Type | Shares |
|---|---|---|
BROSIUS, MARK SVP & Chief Mfg and Supply Cha | Sell | -645 |
| Insider | Type | Shares |
|---|---|---|
BROSIUS, MARK SVP & Chief Mfg and Supply Cha | Sell | -648 |
| Insider | Type | Shares |
|---|---|---|
BROSIUS, MARK SVP & Chief Mfg and Supply Cha | Sell | -648 |
| Insider | Type | Shares |
|---|---|---|
BROSIUS, MARK SVP & Chief Mfg and Supply Cha | Sell | -2,362 |
Data sourced from SEC Form 4 filings
Last updated: 8:32:38 AM
About Intuitive Surgical Inc(ISRG)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.